{
  "extraction_date": "2025-12-23",
  "condition": "HIV",
  "phase": "3",
  "priority": "Expansion",
  "total_studies": 9,
  "studies": [
    {
      "study_id": "CT_NCT03066128",
      "study_type": "RCT",
      "condition": "HIV",
      "study_title": "Point-of-care Viral Load Testing to Enable Streamlined Care and Task Shifting for Chronic HIV Care",
      "citation": "ClinicalTrials.gov NCTNCT03066128",
      "publication_year": 2018,
      "journal": "ClinicalTrials.gov",
      "intervention": {
        "cannabis_type": "cannabis/cannabinoids",
        "cannabinoid_profile": "Cannabis mentioned in study text",
        "delivery_method": "various",
        "dosing_information": "Phase NA",
        "treatment_duration": "clinical trial duration"
      },
      "outcomes": {
        "key_findings": [
          "Composite measure of virological suppression and retention in care"
        ],
        "outcome_measures": [
          "Composite measure of virological suppression and retention in care"
        ],
        "adverse_events": [],
        "evidence_rating": "medium",
        "confidence_level": "medium"
      },
      "metadata": {
        "nct_id": "NCT03066128",
        "enrollment": 390,
        "phase": "NA",
        "source": "ClinicalTrials.gov",
        "url": "https://clinicaltrials.gov/study/NCT03066128"
      }
    },
    {
      "study_id": "CT_NCT03886753",
      "study_type": "Clinical Trial",
      "condition": "HIV",
      "study_title": "Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products",
      "citation": "ClinicalTrials.gov NCTNCT03886753",
      "publication_year": 2020,
      "journal": "ClinicalTrials.gov",
      "intervention": {
        "cannabis_type": "cannabis/cannabinoids",
        "cannabinoid_profile": "Cannabis mentioned in study text",
        "delivery_method": "various",
        "dosing_information": "Phase N/A",
        "treatment_duration": "clinical trial duration"
      },
      "outcomes": {
        "key_findings": [
          "Change in symptoms"
        ],
        "outcome_measures": [
          "Change in symptoms"
        ],
        "adverse_events": [],
        "evidence_rating": "medium",
        "confidence_level": "medium"
      },
      "metadata": {
        "nct_id": "NCT03886753",
        "enrollment": 10,
        "phase": "N/A",
        "source": "ClinicalTrials.gov",
        "url": "https://clinicaltrials.gov/study/NCT03886753"
      }
    },
    {
      "study_id": "CT_NCT04096053",
      "study_type": "RCT",
      "condition": "HIV",
      "study_title": "Transgender Education for Affirmative and Competent HIV and Healthcare",
      "citation": "ClinicalTrials.gov NCTNCT04096053",
      "publication_year": 2020,
      "journal": "ClinicalTrials.gov",
      "intervention": {
        "cannabis_type": "cannabis/cannabinoids",
        "cannabinoid_profile": "Cannabis mentioned in study text",
        "delivery_method": "various",
        "dosing_information": "Phase NA",
        "treatment_duration": "clinical trial duration"
      },
      "outcomes": {
        "key_findings": [
          "Workshop Recruitment Rate",
          "Workshop Completion Rate",
          "Survey completion rate",
          "Satisfaction with the workshop"
        ],
        "outcome_measures": [
          "Workshop Recruitment Rate",
          "Workshop Completion Rate",
          "Survey completion rate",
          "Satisfaction with the workshop"
        ],
        "adverse_events": [],
        "evidence_rating": "medium",
        "confidence_level": "medium"
      },
      "metadata": {
        "nct_id": "NCT04096053",
        "enrollment": 78,
        "phase": "NA",
        "source": "ClinicalTrials.gov",
        "url": "https://clinicaltrials.gov/study/NCT04096053"
      }
    },
    {
      "study_id": "CT_NCT03633721",
      "study_type": "RCT",
      "condition": "HIV",
      "study_title": "Acute Effects of Cannabis on Cognition and Mobility in Older HIV-infected and HIV-Un-infected Women",
      "citation": "ClinicalTrials.gov NCTNCT03633721",
      "publication_year": 2022,
      "journal": "ClinicalTrials.gov",
      "intervention": {
        "cannabis_type": "cannabis/cannabinoids",
        "cannabinoid_profile": "Cannabis",
        "delivery_method": "various",
        "dosing_information": "Phase PHASE2",
        "treatment_duration": "clinical trial duration"
      },
      "outcomes": {
        "key_findings": [
          "Change in Acute Effects of Cannabis on Mobility Gait Speed (m/s)",
          "Change in Acute Effects of Cannabis on Balance - Functional Reach (cm)",
          "Change in Acute Effects of Cannabis on Cognition Using Sustained Attention Response Test (% Correct Suppressions)"
        ],
        "outcome_measures": [
          "Change in Acute Effects of Cannabis on Mobility Gait Speed (m/s)",
          "Change in Acute Effects of Cannabis on Balance - Functional Reach (cm)",
          "Change in Acute Effects of Cannabis on Cognition Using Sustained Attention Response Test (% Correct Suppressions)"
        ],
        "adverse_events": [],
        "evidence_rating": "medium",
        "confidence_level": "medium"
      },
      "metadata": {
        "nct_id": "NCT03633721",
        "enrollment": 25,
        "phase": "PHASE2",
        "source": "ClinicalTrials.gov",
        "url": "https://clinicaltrials.gov/study/NCT03633721"
      }
    },
    {
      "study_id": "CT_NCT00000737",
      "study_type": "RCT",
      "condition": "HIV",
      "study_title": "A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome",
      "citation": "ClinicalTrials.gov NCTNCT00000737",
      "publication_year": 2025,
      "journal": "ClinicalTrials.gov",
      "intervention": {
        "cannabis_type": "cannabis/cannabinoids",
        "cannabinoid_profile": "Dronabinol",
        "delivery_method": "various",
        "dosing_information": "Phase PHASE1",
        "treatment_duration": "clinical trial duration"
      },
      "outcomes": {
        "key_findings": [],
        "outcome_measures": [],
        "adverse_events": [],
        "evidence_rating": "medium",
        "confidence_level": "medium"
      },
      "metadata": {
        "nct_id": "NCT00000737",
        "enrollment": 56,
        "phase": "PHASE1",
        "source": "ClinicalTrials.gov",
        "url": "https://clinicaltrials.gov/study/NCT00000737"
      }
    },
    {
      "study_id": "CT_NCT00642499",
      "study_type": "RCT",
      "condition": "HIV",
      "study_title": "Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting",
      "citation": "ClinicalTrials.gov NCTNCT00642499",
      "publication_year": 2005,
      "journal": "ClinicalTrials.gov",
      "intervention": {
        "cannabis_type": "cannabis/cannabinoids",
        "cannabinoid_profile": "Dronabinol",
        "delivery_method": "various",
        "dosing_information": "Phase PHASE2",
        "treatment_duration": "clinical trial duration"
      },
      "outcomes": {
        "key_findings": [
          "The absence of nausea as indicated by a visual analog scale (VAS) score < 5 mm"
        ],
        "outcome_measures": [
          "The absence of nausea as indicated by a visual analog scale (VAS) score < 5 mm"
        ],
        "adverse_events": [],
        "evidence_rating": "medium",
        "confidence_level": "medium"
      },
      "metadata": {
        "nct_id": "NCT00642499",
        "enrollment": 103,
        "phase": "PHASE2",
        "source": "ClinicalTrials.gov",
        "url": "https://clinicaltrials.gov/study/NCT00642499"
      }
    },
    {
      "study_id": "CT_NCT03099005",
      "study_type": "RCT",
      "condition": "HIV",
      "study_title": "Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain",
      "citation": "ClinicalTrials.gov NCTNCT03099005",
      "publication_year": 2022,
      "journal": "ClinicalTrials.gov",
      "intervention": {
        "cannabis_type": "cannabis/cannabinoids",
        "cannabinoid_profile": "Cannabis",
        "delivery_method": "various",
        "dosing_information": "Phase PHASE2",
        "treatment_duration": "clinical trial duration"
      },
      "outcomes": {
        "key_findings": [
          "Phase 1 - Numerical Pain Rating Scale (NPRS)"
        ],
        "outcome_measures": [
          "Phase 1 - Numerical Pain Rating Scale (NPRS)"
        ],
        "adverse_events": [],
        "evidence_rating": "medium",
        "confidence_level": "medium"
      },
      "metadata": {
        "nct_id": "NCT03099005",
        "enrollment": 5,
        "phase": "PHASE2",
        "source": "ClinicalTrials.gov",
        "url": "https://clinicaltrials.gov/study/NCT03099005"
      }
    },
    {
      "study_id": "CT_NCT00079560",
      "study_type": "RCT",
      "condition": "HIV",
      "study_title": "Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS",
      "citation": "ClinicalTrials.gov NCTNCT00079560",
      "publication_year": 2005,
      "journal": "ClinicalTrials.gov",
      "intervention": {
        "cannabis_type": "cannabis/cannabinoids",
        "cannabinoid_profile": "dronabinol",
        "delivery_method": "various",
        "dosing_information": "Phase PHASE1",
        "treatment_duration": "clinical trial duration"
      },
      "outcomes": {
        "key_findings": [
          "daily caloric intake"
        ],
        "outcome_measures": [
          "daily caloric intake"
        ],
        "adverse_events": [],
        "evidence_rating": "medium",
        "confidence_level": "medium"
      },
      "metadata": {
        "nct_id": "NCT00079560",
        "enrollment": 30,
        "phase": "PHASE1",
        "source": "ClinicalTrials.gov",
        "url": "https://clinicaltrials.gov/study/NCT00079560"
      }
    },
    {
      "study_id": "CT_NCT04866004",
      "study_type": "RCT",
      "condition": "HIV",
      "study_title": "Contingency Management for Cannabis Use for Persons With HIV",
      "citation": "ClinicalTrials.gov NCTNCT04866004",
      "publication_year": 2025,
      "journal": "ClinicalTrials.gov",
      "intervention": {
        "cannabis_type": "cannabis/cannabinoids",
        "cannabinoid_profile": "Contingency Management - Cannabis",
        "delivery_method": "various",
        "dosing_information": "Phase NA",
        "treatment_duration": "clinical trial duration"
      },
      "outcomes": {
        "key_findings": [
          "Sustained cannabis abstinence for 28-days"
        ],
        "outcome_measures": [
          "Sustained cannabis abstinence for 28-days"
        ],
        "adverse_events": [],
        "evidence_rating": "medium",
        "confidence_level": "medium"
      },
      "metadata": {
        "nct_id": "NCT04866004",
        "enrollment": 25,
        "phase": "NA",
        "source": "ClinicalTrials.gov",
        "url": "https://clinicaltrials.gov/study/NCT04866004"
      }
    }
  ],
  "expansion_metadata": {
    "clinicaltrials_gov_added": 9,
    "pubmed_added": 0,
    "total_added": 9,
    "expansion_date": "2025-12-23T23:42:17.463808"
  }
}